다지역 임상시험의 계획 및 설계에 대한 국제 제도적 동향 분석

키워드

참고문헌 (36)

1. EvaluatePharma®, "World Preview 2015, Outlook to 2020", pp.25~ (2015), Evaluate Ltd
2. Shenoy P, "Multi-regional clinical trials and global drug development", Perspect Clin Res, 7, pp.62~67 (2016)[DOI]
3. "Analysis of approval status of '14 clinical trial; 607 in '<TEX>$13{\rightarrow}652$</TEX> in '14"[URL]
4. Maeda H, "Recent trends for drug lag in clinical development of oncology drugs in Japan: does the oncology drug lag still exist in Japan?", Int J Clin Oncol, 20, pp.1072~1080 (2015)[DOI]
5. Yang H, "Investigation on Multi-Regional Clinical Trial (MRCT)", Regulatory Research on Food, Drug & Cosmetic, 9, pp.149~157 (2014)
6. "Basic principles on global clinical trials, Notification No.0928010"[URL]
7. Tanaka A, "How should ethnicity-related information be included on drug labels? Considerations based on comparison of multiregional clinical trial data on the label between Japan and the United States", Clin Pharmacol Ther, 98, pp.480~482 (2015)[DOI]
8. Wang SJ, "Multi-regional clinical trials-what are the challenges?", Pharm Stat, 9, pp.171~172 (2010)[DOI]
9. "ICH harmonised guideline - General principles for planning and design of multi-regional clinical trials E17 (draft), International Concil for Harmonisation"[URL]
10. "ICH harmonised guideline - General principles for planning and design of multi-regional clinical trials E17, International Concil for Harmonisation"[URL]
11. "Demonstrated the level of developed countries by regulating pharmaceuticals through ICH subscription; The sixth member of the regulatory body, including the United States, Europe, and Japan, Raise international credibility and expect pharmaceutical exports to activate"[URL]
12. "US Food and Drug Administration"[URL]
13. "European Medicines Agency"[URL]
14. "Ministry of Health, Labour and Welfare"[URL]
15. "Pharmaceuticals and Medical Devices Agency"[URL]
16. "1China Food and Drug Administration"[URL]
17. "International Concil for Harmonisation"[URL]
18. "Strategy and implementation plan for advancing regulatory science for medical products"[URL]
19. Chakravarty AG, "Multi-regional clinical trials - considerations in design and analysis", Global drug development and its impact on CDER's drug review process symposium (2014)
20. "CFR - Code of Federal Regulations Title 21"[URL]
21. "Guidance for Industry and Food and Drug Administration Staff - collection of race and ethnicity data in clinical trials"[URL]
22. "European Commission DIRECTIVE 2001/20/EC, The European parliament and of the council of 4 April 2001"[URL]
23. "Regulation (EC) No 726/2004 - Community procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency"[URL]
24. "Reflection paper on the extrapolation of results from clinical studies conducted outside of the EU to the EU population (EMEA/CHMP/EWP/692702/2008)"[URL]
25. "Reflection paper on ethical and GCP aspects of clinical trials of medicinal products for human use conducted outside of the EU/EEA and submitted in marketing authorisation applications to the EU Regulatory Authorities (EMA/121340/2011)"[URL]
26. "Guideline on the investigation of subgroups in confirmatory clinical trials (EMA/CHMP/539146/2013)"[URL]
27. "Generic drug evaluation analysis system of important export target country"[URL]
28. Licensing Report Series -5: Japanese drug authorization system, , APEC Harmonization Center, ~ (2016)
29. "Basic principles on global clinical trials (reference cases)"[URL]
30. "Basic principles for conducting phase I trials in the Japanese population prior to global clinical trials"[URL]
31. "Provisions for drug registration (SFDA Order No. 28)"[URL]
32. "Guidance for international multicenter clinical trials trial implementation"[URL]
33. "ICH harmonised guideline - Ethnic factors in the acceptability of foreign clinical data E5 (R1)"[URL]
34. "Final Concept Paper E17: General principle on planning/designing Multi-Regional Clinical Trials dated 21 May 2014"[URL]
35. "Multiregional clinical trials' discussion"[URL]
36. "Korea National Enterprise for Clinical Trial"[URL]

관련 논문AI추천